CLRB
Price
$4.98
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
15.9M
QTTB
Price
$1.67
Change
+$0.01 (+0.60%)
Updated
Sep 5 closing price
Capitalization
20.37M
Interact to see
Advertisement

CLRB vs QTTB

Header iconCLRB vs QTTB Comparison
Open Charts CLRB vs QTTBBanner chart's image
Cellectar Biosciences
Price$4.98
Change-$0.00 (-0.00%)
Volume$62.77K
Capitalization15.9M
Q32 Bio
Price$1.67
Change+$0.01 (+0.60%)
Volume$74.31K
Capitalization20.37M
CLRB vs QTTB Comparison Chart in %
Loading...
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRB vs. QTTB commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRB is a StrongBuy and QTTB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (CLRB: $4.98 vs. QTTB: $1.67)
Brand notoriety: CLRB and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRB: 48% vs. QTTB: 4%
Market capitalization -- CLRB: $15.9M vs. QTTB: $20.37M
CLRB [@Biotechnology] is valued at $15.9M. QTTB’s [@Biotechnology] market capitalization is $20.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRB’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • CLRB’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, QTTB is a better buy in the long-term than CLRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRB’s TA Score shows that 2 TA indicator(s) are bullish while QTTB’s TA Score has 3 bullish TA indicator(s).

  • CLRB’s TA Score: 2 bullish, 3 bearish.
  • QTTB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CLRB is a better buy in the short-term than QTTB.

Price Growth

CLRB (@Biotechnology) experienced а +2.26% price change this week, while QTTB (@Biotechnology) price change was -2.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTTB($20.4M) has a higher market cap than CLRB($15.9M). CLRB YTD gains are higher at: -44.482 vs. QTTB (-51.453). QTTB has higher annual earnings (EBITDA): -33.17M vs. CLRB (-38.26M). QTTB has more cash in the bank: 54.8M vs. CLRB (11M). CLRB has less debt than QTTB: CLRB (454K) vs QTTB (18.7M). CLRB (0) and QTTB (0) have equivalent revenues.
CLRBQTTBCLRB / QTTB
Capitalization15.9M20.4M78%
EBITDA-38.26M-33.17M115%
Gain YTD-44.482-51.45386%
P/E RatioN/AN/A-
Revenue00-
Total Cash11M54.8M20%
Total Debt454K18.7M2%
FUNDAMENTALS RATINGS
CLRB vs QTTB: Fundamental Ratings
CLRB
QTTB
OUTLOOK RATING
1..100
2418
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6590
P/E GROWTH RATING
1..100
75100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (39) in the null industry is in the same range as CLRB (56) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

QTTB's SMR Rating (100) in the null industry is in the same range as CLRB (100) in the Biotechnology industry. This means that QTTB’s stock grew similarly to CLRB’s over the last 12 months.

CLRB's Price Growth Rating (65) in the Biotechnology industry is in the same range as QTTB (90) in the null industry. This means that CLRB’s stock grew similarly to QTTB’s over the last 12 months.

CLRB's P/E Growth Rating (75) in the Biotechnology industry is in the same range as QTTB (100) in the null industry. This means that CLRB’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLRBQTTB
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 12 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMBC14.960.47
+3.24%
Embecta Corp
IRT18.040.26
+1.46%
Independence Realty Trust
TGT93.170.46
+0.50%
Target Corp
SGHT3.69-0.04
-1.07%
Sight Sciences
EHGO0.66-0.02
-3.49%
Eshallgo Inc.

CLRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLRB has been loosely correlated with QTTB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CLRB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRB
1D Price
Change %
CLRB100%
N/A
QTTB - CLRB
65%
Loosely correlated
+0.60%
IBRX - CLRB
42%
Loosely correlated
+0.42%
ADCT - CLRB
40%
Loosely correlated
+4.12%
ANAB - CLRB
35%
Loosely correlated
+3.84%
PRAX - CLRB
35%
Loosely correlated
+1.65%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been loosely correlated with CLRB. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
+0.60%
CLRB - QTTB
65%
Loosely correlated
N/A
MESO - QTTB
51%
Loosely correlated
+6.43%
STOK - QTTB
49%
Loosely correlated
+5.35%
ADCT - QTTB
46%
Loosely correlated
+4.12%
ANAB - QTTB
39%
Loosely correlated
+3.84%
More